Dopl Technologies raises $6.3 million seed round to advance robotic ultrasound platform toward FDA clearance
Dopl Technologies has raised $6.3 million in seed financing to accelerate development and regulatory approval of its telerobotic ultrasound platform, positioning the company to expand access to diagnostic imaging through remotely operated robotic systems.
The funding round was led by SpringTide Ventures and brings the Bothell, Washington-based medical technology company’s total funding to more than $8 million. Additional investors include WRF Capital, Tacoma Venture Fund, HeartX, Transform Health Ventures, Precursor Ventures, and several other early-stage institutional and strategic investors.
The new capital will support product verification and validation, clinical evaluation, FDA submission and clearance activities, and the initial commercial launch of Dopl’s robotic ultrasound ecosystem.
